Back

Impact of zero-contrast percutaneous coronary intervention on renal function in chronic phase

30 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes: revascularisation - miscellaneous and issues Comorbidities ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Chisato Sato

Showa University Koto-Toyosu Hospital, Tokyo (Japan)

5 More presentations in this session

Presentation thumbnail
Relative survival rate during twenty years folow-up in younger patients with STEMI treated by primary percutaneous coronary intervention
Professor P. Tousek (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Comprehensive analysis of medical and invasive treatment strategies for patients with significant left anterior descending artery disease (COMMIT LAD)
Doctor R. Bova (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Age-adjusted calcium score 0: a superior predictor of coronary obstruction absence in suspected acute coronary syndrome.
Doctor I. Chapman (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Fasting versus non-fasting before elective coronary angiography: a randomized clinical trial
Assistant Professor F. Baharvand (Rasht, IR)
Abstract Slides Video
Presentation thumbnail
Progression of coronary artery disease in patients undergoing transcatheter aortic valve replacement: a quantitative flow ratio analysis
Doctor J. Galo (Washington, DC, US)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: revascularisation - miscellaneous and issues

The Event

Event poster

ESC Congress 2025

30 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease
thumbnail
Congress Presentation
Influence of acute kidney injury and chronic kidney disease on 3-year clinical outcomes in patients with AMI treated by contemporary PCI and optimal medical therapy; insights from J-MINUET study
thumbnail
Congress Presentation
Contrast volume to creatinine clearance ratio, a strong predictor of contrast induced nephropathy in patients undergoing percutaneous intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources